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Haemophilus influenzae is a gram-negative bacterium that initiates infection by colonizing the upper respi-
ratory tract. The H. influenzae Hap autotransporter protein mediates adherence, invasion, and microcolony
formation in assays with respiratory epithelial cells and presumably facilitates colonization. The serine
protease activity of Hap is associated with autoproteolytic cleavage and extracellular release of the HapS
passenger domain, leaving the Hap C-terminal domain embedded in the outer membrane. Cleavage occurs
most efficiently at the LN1036-37 peptide bond and to a lesser extent at three other sites. In this study, we
utilized site-directed mutagenesis, homology modeling, and assays with a peptide library to characterize the
structural determinants of Hap proteolytic activity and cleavage specificity. In addition, we used homology
modeling to predict the S1, S2, and S4 subsite residues of the Hap substrate groove. Our results indicate that
the P1 and P2 positions at the Hap cleavage sites are critical for cleavage, with leucine preferred over larger
hydrophobic residues or other amino acids in these positions. The substrate groove is formed by L263 and
N274 at the S1 subsite, R264 at the S2 subsite, and E265 at the S4 subsite. This information may facilitate
design of approaches to block Hap activity and interfere with H. influenzae colonization.
Haemophilus influenzae is a gram-negative coccobacillus that
typically colonizes the nasopharynxes of children and adults. In
addition, this organism is an important cause of localized re-
spiratory tract and invasive disease. Nonencapsulated strains
cause otitis media, sinusitis, conjunctivitis, and exacerbations
of respiratory symptoms in individuals with underlying lung
disease, bronchiectasis, and cystic fibrosis (21, 29). Encapsu-
lated strains are an important cause of bacteremic diseases,
including sepsis and meningitis (29). Colonization of the upper
respiratory tract represents an early step in the pathogenesis of
all Haemophilus disease and requires adherence to respiratory
epithelium (19). Adherence is facilitated by a number of ad-
hesins, including Hap, Hia, Hsf, HMW1/HMW2, P5, pili, and
lipooligosaccharide (2, 18, 21, 26, 27).
The Hap adhesin is ubiquitous among isolates of H. in-
fluenzae and is a member of the autotransporter family of
virulence factors that have been recognized among many
gram-negative bacteria (10). Autotransporters are synthe-
sized as precursor proteins with three functional regions,
namely, an N-terminal signal sequence, an internal passenger
domain, and a C-terminal -barrel domain (11). The signal
sequence targets the precursor protein to the inner membrane
and is then cleaved. The C-terminal -barrel domain inserts
into the outer membrane and facilitates presentation of the
passenger domain on the bacterial cell surface. Depending
upon the protein, the passenger domain remains covalently
attached to the -barrel domain, is cleaved but remains loosely
attached to the -barrel domain, or is cleaved and released
entirely from the cell surface (10–12). Although diverse auto-
transporters share a similar structural organization and a com-
mon secretion mechanism, they vary widely in function, possi-
bly reflecting adaptations to particular bacterial pathogenic
niches. Autotransporters may function as adhesins mediating
tissue tropism, as proteases involved in tissue degradation, as
toxins causing host tissue damage, or as mediators of serum
resistance (11).
Hap is synthesized as a 155-kDa preprotein encompassing a
110-kDa passenger domain, HapS, and a 45-kDa -barrel do-
main, Hap. The HapS passenger domain harbors adhesive
activity that has been shown to promote interactions with hu-
man respiratory cells, as well as with extracellular matrix pro-
teins such as fibronectin, laminin, and collagen IV (7). HapS is
also responsible for bacterial aggregation via Hap-Hap inter-
actions, contributing to microcolony formation (5). Adherence
to epithelial cells and bacterial aggregation are mediated by
the C-terminal 311 amino acids of HapS, whereas interaction
with extracellular matrix proteins is mediated by the C-termi-
nal 511 amino acids of HapS (7).
Beyond possessing adhesive activities, the HapS passenger
domain functions as a protease that directs the autoproteolytic
cleavage of HapS from Hap, resulting in release of HapS from
the bacterial cell surface (6). Hap autoproteolysis has been
determined to occur at least partly through intermolecular
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cleavage on the surface of the bacterium and involves a cata-
lytic triad consisting of residues His98, Asp140, and Ser243.
Ser243 is part of the GDSGS motif that is characteristic of
many serine proteases (6, 13). In wild-type Hap, cleavage
occurs most abundantly at the L1036-N1037 peptide bond,
which is referred to as the primary cleavage site (13). Site-
directed mutagenesis of this site and N-terminal sequencing
of the resulting cleaved Hap fragments has identified three
additional cleavage sites, including L1046-T1047, F1077-
A1078, and F1067-S1068, termed the secondary, tertiary, and
quaternary cleavage sites, respectively (see Table 2) (6). Align-
ment of the amino acid sequences at these cleavage sites has
revealed a consensus target sequence motif that consists of
(Q/R)(A/S)X(L/F) at the P4 through P1 positions (see Table
2) (6).
Hap protease activity can be blocked by selected serine pro-
tease inhibitors, including secretory leukocyte protease inhib-
itor, a component of human respiratory secretions (14). This
inhibition results in accumulation of full-length Hap in the
outer membrane, with HapS on the bacterial surface. Similar to
the effect of serine protease inhibitors, mutation of the active
site serine in the Hap protease domain causes retention of
HapS on the bacterial surface, increased adherence to epithe-
lial cells, increased adherence to extracellular matrix proteins,
increased bacterial aggregation, and increased microcolony
formation, suggesting that Hap protease activity might play a
regulatory role in bacterial adherence. Indeed, autoproteolytic
cleavage of Hap results in reduced adhesive activity (5).
In the present study, we sought to further elucidate the
structural determinants of Hap proteolytic activity. We used
site-directed mutagenesis and in vitro assays with a synthetic
peptide library to characterize Hap cleavage site specificity,
and we used homology modeling and site-directed mutagenesis
to define the Hap substrate groove. We found that the two
residues immediately N-terminal to Hap cleavage sites are
critical for cleavage, with leucine preferred over larger hydro-
phobic residues or other amino acids in these positions. In
addition, we defined the residues that likely form the Hap
substrate groove.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and
plasmids used in the present study are listed in Table 1. Plasmid constructs
encoding hap were expressed in H. influenzae strain DB117, a rec-1 derivative of
TABLE 1. Bacterial strains and plasmids
Strain or plasmida Descriptionb Source or reference
Strains
E. coli DH5 80dlacZM15 lacU169 deoR recA endA1 Life Technologies
H. influenzae DB117 Laboratory strain, rec-1, capsule-deficient serotype d, with
nonsense mutation in hap
23a
Plasmids
pGJB103 E. coli-H. influenzae shuttle vector; Tcr 27a
pJS106 pGJB103 with a 6.7-kb PstI fragment containing hap 26, 27
pMLD100 pUC19 with a 6.7-kb PstI fragment containing hap 13
pHapS243A pJS106 with S243A mutation 13
pHapL1036S pJS106 with L1036S mutation 5
pHapL1036F pJS106 with L1036F mutation This study
pHapL1035S pJS106 with L1035S mutation This study
pHapL1035T pJS106 with L1035T mutation This study
pHapL1035E pJS106 with L1035E mutation This study
pHapE1045L pJS106 with E1045L mutation This study
pHapE1045A pJS106 with E1045A mutation This study
pHapF1077L pJS106 with F1077L mutation This study
pHapF1077L/L1036S pJS106 with F1077L/L1036S mutations This study
pHapF1077L/L1036F pJS106 with F1077L/L1036F mutations This study
pHapF1067L pJS106 with F1067L mutation This study
pHapV1066L pJS106 with V1066L mutation This study
pHapQ1033A pJS106 with Q1033A mutation This study
pHapQ1033E pJS106 with Q1033E mutation This study
pHapS1034F pJS106 with S1034F mutation This study
pHapS1034E pJS106 with S1034E mutation This study
pHapN1037R pJS106 with N1037R mutation This study
pHapA1038S pJS106 with A1038S mutation This study
pHapL1039S pJS106 with L1039S mutation This study
pHapE1040S pJS106 with E1040S mutation This study
pHapY137A pJS106 with Y137A mutation This study
pHapK240A pJS106 with K240A mutation This study
pHapL263R pJS106 with L263R mutation This study
pHapN274R pJS106 with N274R mutation This study
pHapR264A pJS106 with R264A mutation This study
pHapE265A pJS106 with E265A mutation This study
pHapE265R pJS106 with E265R mutation This study
pHapE265W pJS106 with E265W mutation This study
a Plasmids encoding wild-type hap or mutant hap derivatives were expressed in H. influenzae strain DB117.
b Tcr, tetracycline resistance.
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strain Rd that contains a nonfunctional hap gene due to a spontaneous nonsense
mutation in hap. H. influenzae strains were stored at 80°C in brain heart
infusion (BHI) broth with 20% glycerol, grown overnight on supplemented BHI
agar with appropriate antibiotics, and cultivated in BHI broth as described
previously (1). Escherichia coli strain DH5 was grown on Luria-Bertani (LB)
agar or in LB broth and was maintained at 80°C in LB broth with 20% glycerol.
Tetracycline was used at concentrations of 5 g/ml (H. influenzae) and 12.5 g/ml
(E. coli).
Purification of HapS protein. HapS was purified from culture supernatants of
H. influenzae strain DB117/pJS106 as described previously (13).
Glycerol gradient sedimentation and electron microscopy. The sedimentation
coefficient of HapS was estimated by glycerol gradient sedimentation. The puri-
fied protein was sedimented at 20°C through a 15 to 40% glycerol gradient in 0.2
M ammonium bicarbonate at 38,000 rpm for 16 h in a Beckman SW55.1 rotor
(23). The glycerol gradients were calibrated with standard proteins of known S
values (catalase, 11.3 S; aldolase, 7.3 S; bovine serum albumin, 4.6 S; and
ovalbumin, 3.5 S). For rotary shadowing, samples from the glycerol gradient
fractions were sprayed onto freshly cleaved mica, vacuum dried, and rotary
shadowed with platinum (8, 23). For negative staining, purified HapS was applied
to carbon-coated copper grids and stained with 2% uranyl acetate (8, 23).
Construction of mutant Hap derivatives. The plasmid pMLD100 is a pUC19
derivative that contains a 6.7-kb insert with the wild-type hap gene and was used
as a template for PCR. Site-directed mutagenesis was performed using a
QuikChange XL II kit from Stratagene (La Jolla, CA) according to the manu-
facturer’s instructions. The mutations were confirmed by sequencing. After mu-
tagenesis, the 6.7-kb PstI (Roche, Indianapolis, IN) fragment was excised from
pMLD100 and ligated into PstI-digested pGJB103. The resulting plasmids were
introduced into the H. influenzae strain DB117 by MII/MIV transformation (25).
Analysis of outer membrane proteins. H. influenzae strain DB117 derivatives
expressing wild-type Hap or mutant Hap were grown in BHI broth with tetra-
cycline to an optical density at 600 nm of 0.8. Sarkosyl insoluble outer mem-
branes were purified as described previously (4). Outer membrane proteins were
resuspended in a small volume of 10 mM HEPES (pH 7.4), resolved on a 10%
sodium dodecyl sulfate-polyacrylamide gel, and electroblotted onto a nitrocellu-
lose membrane. Immunoblots were probed with antiserum Rab290, which was
raised against a C-terminal Hap fragment corresponding to residues 996 to 1395
and detects the membrane-bound Hap precursors, HapS and Hap. Anti-rabbit
immunoglobulin G conjugated to alkaline phosphatase (Sigma Chemical Co., St.
Louis, MO) was used as a secondary antibody.
Peptide library design and purification. A 12-mer C-terminally biotinylated
peptide library with the sequence NH2-MAXXXXXNALEAKK(biotin)-COOH
was synthesized at the Tufts University Core Facility. In this peptide library, the
P residues were fixed, based on the Hap P1-P5 sequence at the primary
cleavage site (Table 2). An “X” denotes random amino acids at the P1 to P5
positions that were synthesized using an isokinetic mixture of 19 amino acids
(except cysteine). The peptide library was resuspended in phosphate-buffered
saline (PBS; pH 7.4) at a concentration of 3.4 mg/ml. In order to ensure that the
peptide library was homogenously biotinylated, 0.4 mg of the resuspended library
was purified over monomeric avidin agarose (Pierce, Rockford, IL) as described
previously (28). The resulting purified peptide library was lyophilized and resus-
pended in 100 l of assay buffer composed of 50 mM sodium phosphate (pH 7.4).
Peptide library cleavage assay. In order to determine the P residue specificity, 15
l of the purified peptide library was incubated at 37°C overnight with 8 pmol of
purified HapS in a 20-l reaction mixture. Control reactions contained either sub-
strate only (without HapS) or HapS only (without peptide). After incubation, the
samples were heated to 100°C for 5 min to stop the cleavage reaction. The sample
with HapS and peptide was incubated with 0.6 ml of avidin agarose (Sigma) and
rotated at room temperature for 1 h to remove the C-terminal fragments of the
cleaved products, as well as uncleaved peptides. The samples were subjected to
repeated lyophilization, followed by resuspension in water, finally resuspended in 10
l of water, and then subjected to N-terminal sequencing. The peptide fragments
recovered after avidin treatment were sequenced for one cycle beyond the intended
P1 position to test for the removal of unreacted peptides. To determine bias present
in the peptide library itself, the enzyme-free reaction without avidin treatment was
sequenced in the same manner. Raw data from the sequencing reactions were
obtained as molar quantities of each amino acid present in each sequencing cycle.
Corrected experimental data were obtained by dividing the molar percent abun-
dance of each residue in any given sequencing cycle by the molar percent abundance
of that residue in the starting peptide library. These data were normalized to an
average value of 1, resulting in a selective value greater than 1 for residues that were
positively selected and a value less than 1 for residues that were negatively selected.
RESULTS
Electron microscopy of purified HapS. In order to study the
architecture of HapS, we began by purifying HapS from culture
supernatants of H. influenzae strain DB117 expressing wild-
type Hap. As shown in Fig. 1A, the sedimentation coefficient of
purified HapS, as estimated by glycerol gradient sedimentation,
was found to be 5.5 S. This S value of HapS, together with its
known molecular weight, gives rise to an Smax/S value of 1.53,
indicating that HapS has an elongated shape (Fig. 1A) (23). To
further investigate the structure of HapS, we performed rotary
shadowing electron microscopy. As shown in Fig. 1B, this tech-
nique revealed structures that were 15 nm in length and
resembled very short arrowheads (Fig. 1B, middle panel). Sim-
ilar arrowhead-shaped structures were also visible with nega-
tive staining transmission electron microscopy (Fig. 1B, left
panels). The arrowhead shape of HapS resembled the crystal
structure of E. coli hemoglobin protease (Hbp, Fig. 1B, right
panel), a Hap homolog with heme-binding and serine protease
activities that is expressed by clinical isolates associated with
intra-abdominal infections (20, 30). Alignment of the amino
acid sequences of Haps and the protease domain of Hbp re-
vealed an identity of 41% and a similarity of 54%, as high-
lighted in Fig. 2A.
Homology based modeling of the HapS structure. Sequence
alignment using the Pfam server (http://pfam.sanger.ac.uk)
suggested that HapS consists of an N-terminal domain (resi-
dues 70 to 550) sharing 41% sequence identity with Hbp and a
C-terminal domain (residues 851 to 980) sharing 43% se-
quence identity with the Bordetella pertussis Pertactin protein.
To gain further insight into the structure of HapS, we modeled
residues 70 to 550 containing the protease domain based on
the crystal structure of Hbp (PDB code 1WXR) and residues
851 to 980 based on the crystal structure of Pertactin (PBD
code 1DAB) using Swiss-model (http://swissmodel.expasy.org)
and 3Djigsaw (http://bmm.cancerresearchuk.org) homology
modeling servers (Fig. 2B). Based on the Hbp-like shape of
HapS observed by electron microscopy, we modeled the region
between the protease and Pertactin-like domains on the crystal
structure of Hbp, assuming that Hap551-850 shares the same
-helix fold as observed in the Hbp crystal structure and other




P5 P4 P3 P2 P1 P1 P2 P3 P4 P5
Primary
1036-37
D Q S L L N A L E A
Secondary
1046-47
K Q A E L T A E T Q
Tertiary
1077-78
D Q S L F A L E A A
Quaternary
1067-68
K R A V F S D P L L
Peptide
libraryb
M A X X X X X N A L E A K K (biotin)
a The peptide bond where cleavage occurs is between the P1 and P1 columns.
According to nomenclature by Schechter and Berger (22), the residues N ter-
minal to the cleavage site are labeled P1, P2, . . . Pn in the N-terminal direction,
and the residues C-terminal to the cleavage site are labeled P1, P2 . . . Pn.
b The “X” represents any amino acid except Cys. The P residues were fixed
based on the P1 to P5 sequence at the Hap primary cleavage site. The M and
A residues at the N terminus were added in order to validate the first two
residues in the N-terminal sequencing reaction of each peptide.
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conventional autotransporters (31). Hap551-850 was predicted
by the PredictProtein server to be a domain consisting only of
 strands (http://www.predictprotein.org/).
Using the homology model of HapS, we predicted the Hap
substrate groove. First, we aligned Hap63-287 with the pub-
lished crystal structures of alpha-chymotrypsin (PDB code
2CHA) and beta-trypsin (PDB code 5PTP). The structures of
Hap63-287, alpha-chymotrypsin, and beta-trypsin are very sim-
ilar, with a root mean square deviation in C positions of 1.0
Å between Hap63-287 and alpha-chymotrypsin and 2.2 Å be-
tween Hap63-287 and beta-trypsin (Fig. 3A). Next, we inserted
the inhibitor p-sulfinotoluene in these aligned structures to
highlight the catalytic triad and to predict the S subsite resi-
dues of HapS (Fig. 3A). The coordinates of inhibitor p-sulfin-
otoluene were extracted from the superimposed alpha-chymo-
trypsin structure (2CHA) and merged into the homology
model of Hap63-287. By nomenclature, binding sites on a pro-
tease are called subsites (S residues), and each subsite residue
interacts with a residue of the substrate (called P residues)
(22). The predicted S1 subsite contains S243, N274, L263, and
K240; the predicted S2 subsite contains H98, R264, and Y137;
and the predicted S4 subsite contains E265 (Fig. 3B).
Mutagenesis analysis of the predicted substrate groove. To
assess the accuracy of the predicted substrate groove, we per-
formed site-directed mutagenesis, changing each of the pre-
dicted subsite residues individually and assessing the effect of
each mutation on Hap autoproteolytic activity (Table 3). Wild-
type residues were changed to amino acids that differ in terms
of polarity, charge, or length of side chain. For the predicted S1
residues, we changed K240 from a charged amino acid to a
nonpolar amino acid (K240A), L263 from a nonpolar amino
acid to a charged polar amino acid (L263R), and N274 from an
uncharged polar amino acid to a charged polar amino acid
(N274R). For the predicted S2 subsite, we changed Y137 from
an aromatic amino acid to a nonpolar amino acid (Y137A) and
R264 from a charged polar amino acid to a nonpolar amino
acid (R264A). For the predicted S4 subsite, we changed E265
from a charged polar amino acid to nonpolar amino acid
(E265A) or an aromatic amino acid (E265W). In Western blot
analysis of outer membrane preparations from strain DB117
expressing wild-type Hap, a 45-kDa band corresponding to
Hap is apparent, representing cleavage at the primary cleav-
age site (Fig. 4A). By comparison, the N274R and L263R
mutations at the predicted S1 subsite disrupted autoproteoly-
sis, resulting in accumulation of the 155-kDa Hap precursor
(Fig. 4A). Similarly, the R264A mutation at the predicted S2
subsite and the E265W mutation at the predicted S4 subsite
also disrupted autoproteolysis. The E265A mutation had only
a modest effect on autoproteolysis, as evidenced by partial
accumulation of Hap precursor in the outer membrane. In
contrast, the Y137A and K240A mutations had no effect on
autoproteolysis, suggesting that Y137 and K240 may not be
essential for mediating interactions between HapS and its sub-
strate (Fig. 4A). Taken together, these mutagenesis data pro-
vide further support that residues N274, L263, R264, and E265
may indeed form the substrate binding groove in HapS pre-
dicted by our homology model (Fig. 3B).
Analysis of Hap cleavage specificity. In earlier studies we
found that mutation of the P1 residue of the Hap cleavage site
disrupted cleavage (13). To extend these studies, we studied Hap
FIG. 1. (A) Glycerol gradient sedimentation of HapS. HapS sedimented at 5.5 S, with an Smax/S of 1.53. The positions of standard proteins are
indicated by arrows from the left as follows: aldolase (7.3 S), bovine serum albumin (BSA) (4.6 S), and ovalbumin (3.5 S). SM, starting material.
(B) Electron microscopy of purified HapS. Negative staining electron microscopy (upper and lower left panels) and rotary shadow electron
microscopy images (middle panel) of purified HapS revealed an elongated arrowlike shape, which resembled the crystal structure of E. coli Hbp
(right panel). Note that Hap in the rotary shadowed images is slightly larger than the negative stain images because of the platinum shell. The right
panel shows the space-filling model and the overlaid ribbon model of the crystal structure of E. coli Hbp (PDB 1WXR), demonstrating an arrowlike
shape. The serine protease domain is highlighted in red.
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cleavage specificity by systematically mutating the P1 to P4 resi-
dues at cleavage sites and analyzing the effect of these mutations
on autoproteolysis (Table 3). The P1 residue at the primary
(L1036-N1037) and secondary (L1046-T1047) sites is a leucine. In
contrast, the P1 residue at the tertiary (F1077-A1078) and qua-
ternary (F1067-S1068) sites is a phenylalanine (Table 2). To ad-
dress the possibility that leucine at the P1 position is preferred
over the bulkier phenylalanine, leucine in the P1 position at the
primary cleavage site was mutated to phenylalanine (L1036F). In
addition, the bulky phenylalanine in the P1 position at both the
tertiary and quaternary cleavage sites was mutated to leucine
(F1077L and F1067L, respectively). As shown in Fig. 4B, the
previously characterized L1036S mutation (6) that changes the P1
residue at the primary cleavage site to a serine resulted in loss of
cleavage at the primary cleavage site and enhanced cleavage at
the secondary, tertiary, and quaternary cleavage sites. The
L1036F mutation in the present study resulted in slightly dimin-
ished cleavage at the primary cleavage site and enhanced cleavage
at the secondary cleavage site (Fig. 4B). The F1077L mutation
resulted in slightly increased cleavage at the tertiary cleavage site
(Fig. 4B). When the L1036S and the F1077L mutations or the
L1036F and the F1077L mutations were combined, cleavage at
the tertiary site was markedly increased, whereas cleavage at the
primary, secondary, and tertiary sites was markedly diminished
(Fig. 4B). The F1067L mutation resulted in a marked increase in
cleavage at the quaternary site (Fig. 4B). Taken together, these
findings suggest that cleavage after leucine in the P1 position is
more efficient than cleavage after the bulkier phenylalanine in
that position.
The P2 residue at the primary and tertiary cleavage sites is
leucine, while the P2 residue at the secondary cleavage site is
glutamic acid and at the quaternary cleavage site is valine. To
FIG. 2. (A) Sequence alignment between Hap and Hbp serine protease domains. Invariant residues are indicated by an asterisk. The conserved
serine protease motif containing the catalytic serine is underlined. (B) Homology model of HapS. Hap70-550 (red and salmon) was modeled based
on the Hbp structure (PDB code 1WXR). The region highlighted in red corresponds to the serine protease domain. Hap851-980 (yellow) is modeled
based on the Pertactin structure (PDB code 1DAB). Hap551-850 (green) is predicted to be a  domain and is built on the crystal structure of Hbp
based on the appearance of purified HapS by electron microscopy.
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determine whether leucine is preferred in the P2 position, we
initially changed the leucine at the primary cleavage site to polar
residues serine (L1035S) and threonine (L1035T). The L1035S
mutation resulted in diminished cleavage at the primary site and
enhanced cleavage at the secondary, tertiary, and quaternary
sites. The L1035T mutation virtually eliminated all cleavage, re-
sulting in accumulation of the Hap precursor (Fig. 4B). These
data indicate that the P2 position is important for substrate rec-
ognition. In order to further test the P2 position, we changed the
P2 leucine at the primary cleavage site to a glutamic acid
(L1035E), which is also present in the P2 position at the second-
ary cleavage site. The L1035E mutation showed wild-type cleav-
age (Fig. 4B). Next, we changed the glutamic acid in the P2
position at the secondary cleavage site to leucine (E1045L). The
E1045L mutation resulted in prominent cleavage at the secondary
cleavage site and almost no cleavage at the primary, tertiary, and
quaternary cleavage sites (Fig. 4C). To further assess cleavage
preference at the P2 position, we mutated the valine in the P2
position at the quaternary cleavage site to leucine (V1066L). As
shown in Fig. 4C, the V1066L mutation resulted in enhanced
FIG. 3. (A) Stereo ribbon diagram of the superimposed Hap serine protease domain (salmon) and the p-sulfinotoluene bound catalytic alpha
chymotrypsin (blue). The inhibitor, p-sulfinotoluene, and the adjacent catalytic triad of Hap H98, D140, and S243 are shown in stick. (B) Putative
Hap substrate-binding groove. The catalytic triad and the residues that have been tested to be important for Hap autoproteolysis are labeled. L263
and N274 are predicted S1 residues, R264 is a predicted S2 residue, and E265 is a predicted S4 residue. Also labeled are residues K240 and Y137,
which had no effect on autoproteolysis when mutated.
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cleavage at the quaternary cleavage site. These observations in-
dicate that the P2 residue is important in Hap cleavage specificity
and suggest that leucine and glutamic acid are the preferred
residues in this position for Hap proteolysis.
The P3 residue at all four cleavage sites is either a serine or
an alanine. To test the importance of the P3 residue in Hap
proteolysis, we mutated the serine at the primary cleavage site
mutated to phenylalanine (S1034F), a much bulkier residue.
We also changed the serine to a charged polar glutamic acid
(S1034E). Both of these mutations had no effect on autopro-
teolysis (Fig. 4B), suggesting that this position does not signif-
icantly influence Hap cleavage specificity.
The P4 residue is glutamine at the primary, secondary, and
tertiary cleavage sites and arginine at the quaternary site. To
test the importance of the P4 residue, glutamine 1033 at the
primary cleavage site was mutated to alanine, a smaller non-
polar residue (Q1033A), and to glutamic acid, a charged polar
residue (Q1033E). These mutations did not have any effect on
autoproteolysis (Fig. 4C), suggesting that the P4 position is not
an important determinant of Hap proteolysis.
We also investigated the importance of the P residues in Hap
cleavage specificity. However, the mutations N1037R, A1038S,
L1039S, and E1040S at the P1, P2, P3, and P4 positions,
respectively, had no effect on autoproteolysis (Fig. 4C).
Determination of the optimal Hap P motif using a peptide
library. To complement our mutagenesis data and to determine
the optimal Hap cleavage motif at the P4 through P1 positions,
we incubated purified HapS with a C-terminally biotinylated pep-
tide library containing fixed P motifs and randomized amino
acids in the P positions. Figure 5 shows the selectivity ratios for
amino acids selected at each position. Consistent with the mu-
tagenesis data presented here, a leucine residue in both the P1
and the P2 positions strongly favored proteolytic cleavage. Argi-
nine at P1 and glutamic acid at P2 seemed to favor cleavage to a
lesser extent. Glutamic acid seems to be preferred at the P3
position. A number of amino acids had selectivity ratios greater
than 1 at the P4 position, although no strong preference was
evident for any particular amino acid.
DISCUSSION
In this study, we have investigated the Hap cleavage speci-
ficity and substrate groove in detail. Our results demonstrate
that the P1 and P2 residues are important determinants of Hap
cleavage specificity, that small hydrophobic amino acids are
favored in the P1 and P2 positions, and that the substrate
groove likely includes the L263, R264, E265, and N274 amino
acids.
Our earlier work demonstrated that Hap is a member of the
SA (chymotrypsin) clan of serine proteases (6). Interactions
between the P1 residue and the S1 subsite pocket encompass-
ing the residues adjacent to the active site serine are important
determinants of cleavage specificity of chymotrypsinlike pro-
teases (9). For chymotrypsin, cleavage specificity correlates to
the hydrophobicity of the P1 residue and is characterized by
preferential cleavage after tryptophan, tyrosine, or phenylala-






Hap wild type NA 1°, 2°, and 3° cleavage
HapL1036S P1 (1°) No 1° cleavage; 2°, 3°, and 4° cleavage
HapL1036F P1 (1°) 1° cleavage slightly diminished, enhanced secondary cleavage
HapF1077L P1 (3°) Slightly enhanced 3° cleavage
HapF1077L/L1036S P1 (3°) 	 P1 (1°) Enhanced 3° cleavage
HapF1077L/L1036F P1 (3°) 	 P1 (1°) Enhanced 3° cleavage
Hap F1067L P1 (4°) Enhanced 4° cleavage, some 1° and 3° cleavage
HapL1035S P2 (1°) Very little 1° cleavage, enhanced 2° cleavage
HapL1035T P2 (1°) Minimal autoproteolysis, accumulation of Hap precursor
HapL1035E P2 (1°) No effect on autoproteolysis
HapE1045L P2 (2°) Enhanced 2° cleavage
HapE1045A P2 (2°) Enhanced 2° cleavage
HapV1066L P2 (3°) Enhanced 4°, some 1° and 3° cleavage
HapS1034F P3 (1°) No effect on autoproteolysis
HapS1034E P3 (1°) No effect on autoproteolysis
HapQ1033A P4 (1°) No effect on autoproteolysis
HapQ1033E P4 (1°) No effect on autoproteolysis
HapN1037R P1 (1°) No effect on autoproteolysis
HapA1038S P2 (1°) No effect on autoproteolysis
HapL1039S P3 (1°) No effect on autoproteolysis
HapE1040S P4 (1°) No effect on autoproteolysis
HapK240A S1 No effect on autoproteolysis
HapL263R S1 Diminished autoproteolysis, accumulation of Hap precursor
HapN274R S1 Diminished autoproteolysis, accumulation of Hap precursor
HapR264A S2 Diminished autoproteolysis, accumulation of Hap precursor
HapY137A S2 No effect on autoproteolysis
HapE265A S4 Diminished autoproteolysis, accumulation of Hap precursor
HapE265W S4 Diminished autoproteolysis, accumulation of Hap precursor
a All Hap derivatives were expressed in H. influenzae strain DB117.
b Numbers in parentheses indicate the primary (1°), secondary (2°), tertiary (3°), or quaternary (4°) cleavage sites. NA, not applicable.
c Descriptions are based on visual inspection of the blots in triplicate.
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nine, with all of these residues fitting within the deep hydro-
phobic pocket of the protein (16, 17). However, chymotrypsin
can also cleave after leucine, methionine, and histidine in the
P1 position, although with lower efficiency (15, 16). In contrast,
elastase prefers small hydrophobic residues such as alanine in
the P1 position, reflecting a smaller S1 subsite pocket (24). In
the present study, we demonstrated that Hap cleaves with high
preference for leucine over phenylalanine in the P1 position,
suggesting that the S1 subsite pocket in Hap is relatively shal-
low and accommodates small hydrophobic residues better than
bulky residues. This conclusion is consistent with the relative
inefficiency of cleavage at the tertiary and quaternary sites in
wild-type Hap, where the P1 residue is phenylalanine.
In chymotrypsin, proteolysis is also influenced by interaction
between the P2 residue and the S2 subsite pocket (3). In this
context, it is noteworthy that our work supports an important
role for the P2 residue in Hap cleavage specificity, with leucine
or glutamic acid favored over other amino acids. Interestingly,
insertion of leucine in the P2 position at the secondary cleav-
age site (HapE1045L) results in a preference for this cleavage
site to the exclusion of other cleavage sites. It is possible that
these mutations result in local steric hindrance that causes
increased binding of the mutant substrate and more efficient
cleavage at the secondary cleavage site. However, without a
high-resolution crystal structure, we cannot explain the appar-
ent preference of the secondary cleavage site over the primary
cleavage site in this mutant. We also found that insertion of
glutamic acid at the P2 position (L1035E) of the primary cleav-
age site had no significant effect on autoproteolysis. Consistent
with this finding, glutamic acid is the P2 residue at the native
secondary cleavage site (E1045).
Hap cleavage of a random peptide library revealed high
preference for leucine at the P1 and P2 positions, agreeing with
our mutagenesis results. Interestingly, phenylalanine was not
selected at either of these positions, despite the fact that cleav-
age occurs naturally at F1067 and F1077 in wild-type Hap
(albeit to a lesser extent than with leucine in the P1 position).
In considering this information, it is possible that the S1 and S2
subsites in the Hap proteolytic pocket have reduced affinity for
phenylalanine in the context of linear peptides compared to
native folded protein. Based on selectivity ratios, arginine at
the P1 position and glutamic acid at the P2 position seem to be
the favored amino acids after leucine. Serine and threonine
have the lowest selectivity ratio at the P1 and P2 positions,
indicating that they have an inhibitory effect on proteolytic
cleavage, in agreement with our mutagenesis data (L1036S,
L1035S, and L1035T). Further analysis of the peptide library
cleavage assay revealed that glutamic acid was selected at the
P3 position and that a number of amino acids were selected at
the P4 position.
Considered together, our mutational analysis and our pep-
tide library cleavage results indicate that the P1 and P2 resi-
dues are important determinants of Hap cleavage specificity.
Previously, we reported a consensus cleavage site sequence
based only on alignment of the primary, secondary, tertiary,
and quaternary cleavage sites (6). In the present study, muta-
tional analysis reveals a target motif that consists of XX(L/E/
V)(L/F) and the peptide library cleavage assay reveals a target
motif of XE(L/E)(L/R) at the P4 through P1 positions for the
HapS protease. The difference in results between mutational
FIG. 4. Western blots of outer membrane proteins purified from Hap
mutant derivatives. The presence of Hap in the outer membrane was de-
tected using antibody Rab290 raised against the C-terminal Hap fragment
encompassing residues 996 to 1395. (A) Mutagenesis analysis of predicted
Hap substrate binding groove. (B and C) Mutagenesis analysis of Hap cleav-
age specificity. Full-length Hap is seen at 155 kDa, and Hap species are seen
at 45 to 39 kDa. The different Hap derivatives result from cleavage at the
different cleavage sites and are labeled “1” for primary cleavage (45 kDa), “2”
for secondary cleavage (43 kDa), “3” for tertiary cleavage (39 kDa), and “4”
for quaternary cleavage (41 kDa). Immunoblots shown here are representa-
tive of blots performed in triplicate. Assessment of cleavage at the various
cleavage sites was performed by manual inspection.
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analysis and peptide library cleavage may be due to the intrin-
sic difference between cleavage of full-length folded protein
and linear peptides. Mutations introduced at the P residues of
the primary cleavage site had no effect on autoproteolysis,
indicating that these residues do not significantly affect pro-
teolytic cleavage.
In an effort to define the Hap substrate binding groove, we
developed a homology model based on the crystal structures of
the E. coli Hbp and the B. pertussis Pertactin autotransporters.
Guided by this model, we performed site-directed mutagene-
sis, changing residues at the predicted S1, S2, and S4 subsites.
Our results demonstrated that L263, N274, R264, and E265
are critical for efficient autoproteolysis, supporting a role for
these residues in forming the Hap substrate groove and inter-
acting intimately with substrate residues. Mutations at Y137
and K240 that are located at the rim of S1 and S2 subsites in
our model did not affect autoproteolysis.
The implication of the Hap serine protease domain in the
pathogenesis of H. influenzae disease could be twofold. First,
autoproteolytic release of HapS from the bacterial surface may
allow the organism to modulate interactions with host tissues
during various stages of colonization and infection. Second, the
secreted Hap protease domain may have activity against host
substrates such as extracellular matrix proteins or immune
factors. We have previously determined that Hap can bind to
various extracellular matrix proteins such as fibronectin, colla-
gen IV, and laminin (7). Further investigation is needed to
determine whether Hap protease activity might facilitate
spread to deeper tissues or promote persistence in the face of
the host immune response.
In conclusion, in this study we have provided important
insights into the structural determinants of H. influenzae Hap
proteolytic activity. Complete knowledge of the Hap substrate
groove and cleavage specificity may facilitate the design of
therapeutic agents that block Hap proteolytic activity and
thereby attenuate H. influenzae disease.
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